Ucommune International Ltd (UK) - Dilution Analysis

Visualizing historical and potential share dilution over time

Dilution Analysis

High Risk
Significant dilution risk
Last updated: March 24, 2026

Risk Assessment Details

Potential Dilution: 341.84% of current shares
Recent Dilution: 121.77% (2 years)
Historical Dilution Factor: significant recent dilution
Outstanding Shares
4.4M
Potential Supply
15M
Additional shares possible
Splits
None
Past 2 years

Summary

UK currently has 4.44M outstanding shares. with significant dilution risk as 15.2M authorized shares could dilute existing holders by 341.8%. The company has significantly diluted shareholders by 121.77% over the past 2 years, indicating aggressive capital raising.

Share Structure Timeline

Outstanding Shares
Total Supply

Historical Data Points

Date Event Outstanding Supply
Mar 24, 2026

20-F filing | 4.4M shares outstanding

4.4M 15M
Apr 29, 2025

20-F filing | 2.0M shares outstanding

2M 15M
Apr 25, 2024

20-F filing | 0.6M shares outstanding

590K 15M
Apr 25, 2023

20-F filing | 4.7M shares outstanding

4.7M 15M
Aug 16, 2022

F-3 filing: Ucommune International Ltd intends to offer securities, including Class A ordinary shares, preferred shares and debt securities, up to a total amount of US$300,000,000.

78M 15M
May 10, 2022

20-F filing | 77.9M shares outstanding

78M 15M
Jul 02, 2021

F-1 filing: Registration of the resale of Class A ordinary shares, issuance of Class A ordinary shares upon exercise of warrants and options.

78M 15M
Jun 02, 2021

POS AM filing: This is a POS AM filing for Class A ordinary shares, warrants to purchase Class A ordinary shares, and rights to convert to Class A ordinary shares.

78M 6M
May 17, 2021

20-F filing | 80.5M shares outstanding

80M 6M
Mar 18, 2021

F-1 filing: This F-1 filing includes the registration of Class A ordinary shares for resale and issuance upon exercise of warrants and options.

76M 6M
Jan 20, 2021

F-1 filing: This F-1 filing registers Class A ordinary shares and warrants to purchase Class A ordinary shares, with an option for the underwriter to purchase additional shares and warrants. The proceeds are intended for expansion, technology, and working capital.

71M 6M
Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime